Skip to content

Robin Carhart-Harris

Imperial College London, Multidisciplinary Association for Psychedelic Studies

312 papers in the library · 30,055 citations · publishing 2007-2026

Papers

Sort Most recent Most cited

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

The Lancet Psychiatry May 17, 2016 Robin Carhart-Harris, Mark Bolstridge, James Rucker et al. 1,546 citations

BACKGROUND: Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol dependence, with promising preliminary results. Here, we aimed to investigate the feasibility, safety, and efficacy...

DOI: 10.1016/s2215-0366(16)30065-7 (opens in new tab) Psilocybin Depression treatment Mental health research

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Human Brain Mapping April 29, 2016 Leor Roseman, Martin I. Sereno, Robert Leech et al. 63 citations

The question of how spatially organized activity in the visual cortex behaves during eyes-closed, lysergic acid diethylamide (LSD)-induced "psychedelic imagery" (e.g., visions of geometric patterns and more complex phenomena) has never been empirically addressed, although it has been proposed that under psychedelics, with eyes-closed, the brain may function "as if" there is visual input when...

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.

Current Biology April 13, 2016 Enzo Tagliazucchi, Leor Roseman, Mendel Kaelen et al. 531 citations

Lysergic acid diethylamide (LSD) is a non-selective serotonin-receptor agonist that was first synthesized in 1938 and identified as (potently) psychoactive in 1943. Psychedelics have been used by indigenous cultures for millennia [1]; however, because of LSD's unique potency and the timing of its discovery (coinciding with a period of major discovery in psychopharmacology), it is generally...

LSD modulates music-induced imagery via changes in parahippocampal connectivity.

European Neuropsychopharmacology April 12, 2016 Mendel Kaelen, Leor Roseman, Joshua Kahan et al. 143 citations

Psychedelic drugs such as lysergic acid diethylamide (LSD) were used extensively in psychiatry in the past and their therapeutic potential is beginning to be re-examined today. Psychedelic psychotherapy typically involves a patient lying with their eyes-closed during peak drug effects, while listening to music and being supervised by trained psychotherapists. In this context, music is...

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Proceedings of the National Academy of Sciences April 11, 2016 Robin Carhart-Harris, Suresh Muthukumaraswamy, Leor Roseman et al. 887 citations

Lysergic acid diethylamide (LSD) is the prototypical psychedelic drug, but its effects on the human brain have never been studied before with modern neuroimaging. Here, three complementary neuroimaging techniques: arterial spin labeling (ASL), blood oxygen level-dependent (BOLD) measures, and magnetoencephalography (MEG), implemented during resting state conditions, revealed marked changes in...

DOI: 10.1073/pnas.1518377113 (opens in new tab) Full text (opens in new tab) LSD Compound Brain networks Global connectivity Brain function +6

A placebo-controlled investigation of synaesthesia-like experiences under LSD.

Neuropsychologia April 5, 2016 Devin B. Terhune, David Luke, Mendel Kaelen et al. 45 citations

The induction of synaesthesia in non-synaesthetes has the potential to illuminate the mechanisms that contribute to the development of this condition and the shaping of its phenomenology. Previous research suggests that lysergic acid diethylamide (LSD) reliably induces synaesthesia-like experiences in non-synaesthetes. However, these studies suffer from a number of methodological limitations...

The paradoxical psychological effects of lysergic acid diethylamide (LSD)

Psychological Medicine February 5, 2016 Robin Carhart-Harris, Mendel Kaelen, Mark Bolstridge et al. 301 citations

Background Lysergic acid diethylamide (LSD) is a potent serotonergic hallucinogen or psychedelic that modulates consciousness in a marked and novel way. This study sought to examine the acute and mid-term psychological effects of LSD in a controlled study. Method A total of 20 healthy volunteers participated in this within-subjects study. Participants received LSD (75 µ g, intravenously) on one...

Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide

Journal of Psychopharmacology 2016 Jana Speth, Clemens Speth, Mendel Kaelen et al. 119 citations

This paper reports on the effects of LSD on mental time travel during spontaneous mentation. Twenty healthy volunteers participated in a placebo-controlled crossover study, incorporating intravenous administration of LSD (75 μg) and placebo (saline) prior to functional magnetic resonance imaging (fMRI). Six independent, blind judges analysed mentation reports acquired during structured...

DOI: 10.1177/0269881116628430 (opens in new tab) Full text (opens in new tab) Mental health Cognitive health Emotional well-being Brain research +14

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

Human Brain Mapping May 22, 2015 Alexander V. Lebedev, Martin Lövdén, Gidon Rosenthal et al. 347 citations

Ego-disturbances have been a topic in schizophrenia research since the earliest clinical descriptions of the disorder. Manifesting as a feeling that one's "self," "ego," or "I" is disintegrating or that the border between one's self and the external world is dissolving, "ego-disintegration" or "dissolution" is also an important feature of the psychedelic experience, such as is produced by...

Drug models of schizophrenia.

Therapeutic Advances in Psychopharmacology February 1, 2015 Hannah Steeds, Robin Carhart-Harris, James Stone 132 citations

Schizophrenia is a complex mental health disorder with positive, negative and cognitive symptom domains. Approximately one third of patients are resistant to currently available medication. New therapeutic targets and a better understanding of the basic biological processes that drive pathogenesis are needed in order to develop therapies that will improve quality of life for these patients....

A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment

Current Drug Abuse Reviews January 9, 2015 Samuel Turton, D.j. Nutt, Robin Carhart-Harris 48 citations

This article documents the phenomenology of psilocybin when given in a novel manner (intravenous injection) and setting (an MRI scanner). The findings of the analysis are consistent with previous published work regarding the subjective effects of psilocybin. There is much scope for further research investigating the phenomena identified in this paper.

DOI: 10.2174/1874473708666150107120930 (opens in new tab) Psilocybin Phenomenology philosophy Hallucinogen Interpretative phenomenological analysis +4

Homological scaffolds of brain functional networks

Journal of the Royal Society, Interface October 29, 2014 Giovanni Petri, Paul Expert, Federico Turkheimer et al. 689 citations

Networks, as efficient representations of complex systems, have appealed to scientists for a long time and now permeate many areas of science, including neuroimaging (Bullmore and Sporns 2009 Nat. Rev. Neurosci. 10 , 186–198. ( doi:10.1038/nrn2618 )). Traditionally, the structure of complex networks has been studied through their statistical properties and metrics concerned with node and link...

DOI: 10.1098/rsif.2014.0873 (opens in new tab) Centrality Modularity biology Leverage statistics Artificial intelligence +3

Enhanced repertoire of brain dynamical states during the psychedelic experience

Human Brain Mapping July 3, 2014 Enzo Tagliazucchi, Robin Carhart-Harris, Robert Leech et al. 423 citations

Abstract The study of rapid changes in brain dynamics and functional connectivity (FC) is of increasing interest in neuroimaging. Brain states departing from normal waking consciousness are expected to be accompanied by alterations in the aforementioned dynamics. In particular, the psychedelic experience produced by psilocybin (a substance found in “magic mushrooms”) is characterized by...

DOI: 10.1002/hbm.22562 (opens in new tab) Full text (opens in new tab) Cognitive science Repertoire Communication Cognitive psychology

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers

Frontiers in Human Neuroscience May 27, 2014 Leor Roseman, Robert Leech, Amanda Feilding et al. 293 citations

Perturbing a system and observing the consequences is a classic scientific strategy for understanding a phenomenon. Psychedelic drugs perturb consciousness in a marked and novel way and thus are powerful tools for studying its mechanisms. In the present analysis, we measured changes in resting-state functional connectivity (RSFC) between a standard template of different independent components...

Enhanced repertoire of brain dynamical states during the psychedelic experience

arXiv Preprint Archive May 26, 2014 Enzo Tagliazucchi, Robin Carhart-Harris, Robert Leech et al. preprint

The study of rapid changes in brain dynamics and functional connectivity (FC) is of increasing interest in neuroimaging. Brain states departing from normal waking consciousness are expected to be accompanied by alterations in the aforementioned dynamics. In particular, the psychedelic experience produced by psilocybin (a substance found in `magic mushrooms`) is characterized by unconstrained...

Full text (opens in new tab) Q-bio.nc Psychedelics Consciousness Brain connectivity

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

Biological Psychiatry January 10, 2014 Robin Carhart-Harris, Kevin Murphy, Robert Leech et al. 182 citations

The MTLs appear to be specifically implicated in the mechanism of action of MDMA, but further work is required to elucidate how the drug's characteristic subjective effects arise from its modulation of spontaneous brain activity.

DOI: 10.1016/j.biopsych.2013.12.015 (opens in new tab) MDMA Euphoriant Cerebral blood flow Amygdala +5

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs

Frontiers in Human Neuroscience 2014 Robin Carhart-Harris, Robert Leech, Peter J. Hellyer et al. 1,289 citations

Entropy is a dimensionless quantity that is used for measuring uncertainty about the state of a system but it can also imply physical qualities, where high entropy is synonymous with high disorder. Entropy is applied here in the context of states of consciousness and their associated neurodynamics, with a particular focus on the psychedelic state. The psychedelic state is considered an exemplar...

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories

The International Journal of Neuropsychopharmacology December 17, 2013 Robin Carhart-Harris, Matthew B. Wall, David Erritzøe et al. 110 citations

3,4-methylenedioxymethamphetamine (MDMA) is a potent monoamine-releaser that is widely used as a recreational drug. Preliminary work has supported the potential of MDMA in psychotherapy for post-traumatic stress disorder (PTSD). The neurobiological mechanisms underlying its putative efficacy are, however, poorly understood. Psychotherapy for PTSD usually requires that patients revisit traumatic...

Broadband Cortical Desynchronization Underlies the Human Psychedelic State

Journal of Neuroscience September 18, 2013 Matthew J. Brookes, David Errtizoe, Ben Sessa et al. 501 citations

Psychedelic drugs produce profound changes in consciousness, but the underlying neurobiological mechanisms for this remain unclear. Spontaneous and induced oscillatory activity was recorded in healthy human participants with magnetoencephalography after intravenous infusion of psilocybin—prodrug of the nonselective serotonin 2A receptor agonist and classic psychedelic psilocin. Psilocybin...

Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis

Schizophrenia Bulletin October 6, 2012 Robin Carhart-Harris, Robert Leech, David Erritzøe et al. 267 citations

Psilocybin is a classic psychedelic and a candidate drug model of psychosis. This study measured the effects of psilocybin on resting-state network and thalamocortical functional connectivity (FC) using functional magnetic resonance imaging (fMRI). Fifteen healthy volunteers received intravenous infusions of psilocybin and placebo in 2 task-free resting-state scans. Primary analyses focused on...

Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin

The British Journal of Psychiatry January 27, 2012 Robin Carhart-Harris, Robert Leech, Tom A. Williams et al. 241 citations

Background Psilocybin is a classic psychedelic drug that has a history of use in psychotherapy. One of the rationales for its use was that it aids emotional insight by lowering psychological defences. Aims To test the hypothesis that psilocybin facilitates access to personal memories and emotions by comparing subjective and neural responses to positive autobiographical memories under psilocybin...

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Proceedings of the National Academy of Sciences January 23, 2012 Alessandro Colasanti, Robin J. Tyacke, Robert Leech et al. 1,191 citations

Psychedelic drugs have a long history of use in healing ceremonies, but despite renewed interest in their therapeutic potential, we continue to know very little about how they work in the brain. Here we used psilocybin, a classic psychedelic found in magic mushrooms, and a task-free functional MRI (fMRI) protocol designed to capture the transition from normal waking consciousness to the...

The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability

Journal of Psychopharmacology April 15, 2010 Ben Sessa, Amanda Feilding, Robin Carhart-Harris et al. 53 citations

This study sought to assess the tolerability of intravenously administered psilocybin in healthy, hallucinogen-experienced volunteers in a mock-magnetic resonance imaging environment as a preliminary stage to a controlled investigation using functional magnetic resonance imaging to explore the effects of psilocybin on cerebral blood flow and activity. The present pilot study demonstrated that...

DOI: 10.1177/0269881110367445 (opens in new tab) Psilocybin Hallucinogen Tolerability Magnetic resonance imaging +2

Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.

Psychopharmacology July 8, 2009 Robin Carhart-Harris, David Nutt, Marcus R. Munafò et al.

Introduction: This study sought to test the association between 3,4-methylenedioxymethamphetamine use, serotonergic function and sleep. Materials and methods: Ambulatory polysomnography was used to measure three nights sleep in 12 ecstasy users and 12 controls after screening (no intervention), a tryptophan-free amino acid mixture (acute tryptophan depletion (ATD)) and a tryptophan-supplemented...

DOI: 10.1007/s00213-009-1595-3 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders N-methyl-3,4-methylenedioxyamphetamine Tryptophan +9